Organoid-Based Assessment of Metal–Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy
ACS Applied Materials & Interfaces · 03.07.2024 · 16 (26) · 33070-33080
DOI: 10.1021/acsami.4c05172 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 21.06.2024. Verfasst von Dan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Smart Biomedical Materials, School of Materials Science & Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, PR China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Organoids, Nanomedicine. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Zhejiang Sci-Tech University, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Smart Biomedical Materials, School of Materials Science & Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, PR China.
- Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, PR China.
- Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, PR Chi…
ORCID-Profile: Ruibo Zhao
Förderung
- Zhejiang Sci-Tech University
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Science and Technology Program of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Li, D., Zhang, R., Le, Y., Zhang, T., Luo, D., Zhang, H., Li, J., Zhao, R., Hu, Y., & Kong, X. (2024). Organoid-Based Assessment of Metal–Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy. ACS Applied Materials & Interfaces, 16(26), 33070-33080. https://doi.org/10.1021/acsami.4c05172
Vancouver
Li D, Zhang R, Le Y, Zhang T, Luo D, Zhang H, et al. Organoid-Based Assessment of Metal–Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy. ACS Applied Materials & Interfaces. 2024;16(26):33070-33080. doi:10.1021/acsami.4c05172
BibTeX
@article{Li2024,
author = {Li, Dan and Zhang, Rui and Le, Yinpeng and Zhang, Ting and Luo, Dandan and Zhang, Han and Li, Jun and Zhao, Ruibo and Hu, Yeting and Kong, Xiangdong},
title = {Organoid-Based Assessment of Metal–Organic Framework (MOF) Nanomedicines for Ex Vivo Cancer Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {26},
pages = {33070--33080},
doi = {10.1021/acsami.4c05172}
}
EUVIMED